News

Podcast

Insights from a Pharmacy Times Peer Exchange: ADC Drug Design and HER2 Ultra-Low Breast Cancer Indiciations

Author(s):

Alexandra Gerlach, Associate Editor

Pharmacists discuss how drug design impacts drug efficacy and indications for HER2-low and -ultra-low breast cancer.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Pharmacist and doctor -- Image credit: ake1150 | stock.adobe.com
Related Content
Computer Screen in Hospital Radiology Room: Beautiful Multiethnic Adult Woman Standing Topless Undergoing Mammography Screening Procedure. Screen Showing the Mammogram Scans of Dense Breast Tissues - Image credit: Gorodenkoff | stock.adobe.com
September 2nd 2025

Abemaciclib Plus Endocrine Therapy Improves Overall Survival in High-Risk Early Breast Cancer

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus Oncology Edition Podcast
September 2nd 2025

Protecting Community Oncology Practices in the Wake of the IRA

Alexandra Gerlach, Associate Editor
Doctor making a vaccination - Image credit: guerrieroale | stock.adobe.com
September 2nd 2025

New Clinical Guidance Recommends Vaccines to Protect Cardiovascular Patients From Respiratory Illness

Kennedy Ferruggia, Assistant Editor
From Guidelines to Action: Pharmacy’s Role in Hypertension Management
September 2nd 2025

From Guidelines to Action: Pharmacy’s Role in Hypertension Management

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Hands Trim Cannabis Plant Marijuana Indoor Farm | Image Credit: The Colonel | stock.adobe.com
September 2nd 2025

Understanding Cannabis-Linked Paranoia: Motives, Trauma, and Clinical Implications

Danielle Valletti, Assistant Editor
Acute kidney injury (AKI) from chronic kidney disease (CKD) -- Image credit: Rasi | stock.adobe.com
September 2nd 2025

Mitochondria-Targeted Therapies May Transform Acute Kidney Injury Treatment

Gillian McGovern, Associate Editor